what happens when you stop using glp 1 GLP-1 Survey: 37.5% of People GLP-1s after Just 3 Months What Happens When Patients Stop

CagriSema , a combination of cagrilintide (an amylin analog) and semaglutide, is another promising option that adds amylin receptor activation to GLP-1 agonism

Meals above 500 calories may be too large for a suppressed appetite

Duca A, Sturza A, Moac EA, Negrea M, Lalescu VD, Lungeanu D, Dehelean CA, Muntean DM, Alexa E

The analysis, published in the Endocrine Journal , saw a 266% increase of DVT in patients taking semaglutide drugs, such as Ozempic and Wegovy

The improvements were observed in aging-related measures associated with the blood, brain, heart, liver, kidneys, and metabolic health, suggesting potentially broad systemic effects